Sun Pharma Advanced Research Company Ltd submitted an IND application for its drug SBO-154 to the US FDA on March 31, 2025, aiming to start global Phase 1 clinical trials for advanced solid tumors.
AI Assistant
Sun Pharma Advanced Research Company Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.